
Microlab on a chip for clean water
A microfluidic chip takes up a water sample, adds the necessary chemicals and transports it to the detection site.
A microfluidic chip takes up a water sample, adds the necessary chemicals and transports it to the detection site.
Scientists have developed a simple method of extracting tiny biological particles from a person's blood and use them as biomarkers to assess the health of their blood vessels.
Fraunhofer-Gesellschaft's German-Polish High-Performance Center brings additive manufacturing to medical technology – first demonstrators will already be presented by the end of 2021.
Progressive Mechanoporation makes it possible to mechanically disrupt the membranes of cells for a short time period and let drugs or genes inside cells.
The new device can continuously sense levels of virtually any protein or molecule in the blood. The researchers say it could be transformative for disease detection, patient monitoring and biomedical research.
A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing.
With soaring demand for point-of-care testing (POCT), microfluidics has been a pivotal resource as COVID-19 swept across the world.
The supplier sector will showcase its expertise and innovative high-tech solutions for the medical technology industry.
Researchers have created fundamental electronic building blocks out of tiny structures known as quantum dots and used them to assemble functional logic circuits.
Researchers have 3D printed unique fluid channels at the micron scale that could automate production of diagnostics, sensors, and assays used for a variety of medical tests and other applications.
Researchers have developed a way to 3D print custom microswimmers that can transport drugs and nanotherapeutic agents, as well as potentially manipulate tissue directly inside the body.
A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
A new ultrasensitive diagnostic device could allow doctors to detect cancer quickly from a droplet of blood or plasma, leading to timelier interventions and better outcomes for patients.
Researchers are developing early detection technology for Type 1 diabetes that can accurately predict if a child is at risk of the chronic disease.
A wide range of fetal genetic abnormalities could soon be detected in early pregnancy thanks to researchers using lab-on-a-chip, non-invasive technology.
Researchers have created an automated blood drawing and testing device that provides rapid results,could speed hospital work, enhance healthcare.